Novartis AG Revenue 2006-2020 | NVS

Novartis AG annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Novartis AG revenue for the quarter ending June 30, 2020 was $11.622B, a 3.34% decline year-over-year.
  • Novartis AG revenue for the twelve months ending June 30, 2020 was $49.528B, a 5.92% increase year-over-year.
  • Novartis AG annual revenue for 2019 was $48.677B, a 5.59% increase from 2018.
  • Novartis AG annual revenue for 2018 was $46.099B, a 8.05% decline from 2017.
  • Novartis AG annual revenue for 2017 was $50.135B, a 1.41% increase from 2016.
Novartis AG Annual Revenue
(Millions of US $)
2019 $48,677
2018 $46,099
2017 $50,135
2016 $49,436
2015 $50,387
2014 $53,634
2013 $52,716
2012 $51,971
2011 $59,375
2010 $51,561
2009 $45,103
2008 $42,584
2007 $38,947
2006 $35,105
2005 $29,753
Novartis AG Quarterly Revenue
(Millions of US $)
2020-06-30 $11,622
2020-03-31 $12,708
2019-12-31 $12,716
2019-09-30 $12,482
2019-06-30 $12,024
2019-03-31 $11,455
2018-12-31 $11,897
2018-09-30 $11,386
2018-06-30 $11,653
2018-03-31 $11,163
2017-12-31 $13,164
2017-09-30 $12,692
2017-06-30 $12,494
2017-03-31 $11,785
2016-12-31 $12,606
2016-09-30 $12,341
2016-06-30 $12,679
2016-03-31 $11,810
2015-12-31 $12,804
2015-09-30 $12,485
2015-06-30 $12,896
2015-03-31 $12,202
2014-12-31 $13,354
2014-09-30 $13,300
2014-06-30 $13,949
2014-03-31 $13,031
2013-12-31 $12,324
2013-09-30 $12,906
2013-06-30 $13,280
2013-03-31 $14,206
2012-12-31 $9,478
2012-09-30 $14,039
2012-06-30 $14,541
2012-03-31 $13,913
2011-12-31 $14,996
2011-09-30 $15,034
2011-06-30 $15,123
2011-03-31 $14,222
2010-12-31 $14,464
2010-09-30 $12,820
2010-06-30 $11,921
2010-03-31 $12,356
2009-12-31 $13,145
2009-09-30 $11,290
2009-06-30 $10,742
2009-03-31 $9,926
2008-12-31 $10,348
2008-09-30 $11,030
2008-06-30 $10,990
2008-03-31 $10,216
2007-12-31 $10,171
2007-09-30 $9,818
2007-06-30 $9,584
2007-03-31 $9,374
2006-12-31 $9,260
2006-09-30 $9,024
2006-06-30 $8,671
2006-03-31 $8,150
2005-12-31 $5,980
2005-09-30 $8,489
2005-06-30 $7,870
2005-03-31 $7,414
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $189.756B $47.498B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.238B 18.64
Roche Holding AG (RHHBY) Switzerland $294.553B 0.00
Pfizer (PFE) United States $213.583B 13.35
Merck (MRK) United States $204.919B 14.62
AbbVie (ABBV) United States $163.988B 9.99
Novo Nordisk (NVO) Denmark $152.214B 24.77
Eli Lilly (LLY) United States $146.273B 22.33
AstraZeneca (AZN) United Kingdom $145.417B 28.27
Sanofi (SNY) $128.988B 15.33
GlaxoSmithKline (GSK) United Kingdom $102.323B 13.42
Bayer (BAYRY) Germany $61.403B 8.85
H Lundbeck (HLUYY) Denmark $7.388B 12.84
Innoviva (INVA) United States $1.369B 6.56